|
|
Volumn 15, Issue 3, 2010, Pages 234-
|
|
Molecularly targeted therapy for hepatocellular carcinoma from the basic and clinical aspects
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BCR ABL PROTEIN;
STEM CELL FACTOR RECEPTOR;
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
CANCER CHEMOTHERAPY;
CANCER INCIDENCE;
CANCER RECURRENCE;
CARCINOGENESIS;
CLINICAL RESEARCH;
EDITORIAL;
HUMAN;
LIVER CELL CARCINOMA;
MEDICAL INFORMATION;
MOLECULARLY TARGETED THERAPY;
PREVALENCE;
PRIORITY JOURNAL;
TREATMENT INDICATION;
VIRUS HEPATITIS;
ANIMAL;
CARCINOMA, HEPATOCELLULAR;
DRUG EFFECTS;
GENETICS;
LIVER NEOPLASMS;
METABOLISM;
NEOVASCULARIZATION, PATHOLOGIC;
SIGNAL TRANSDUCTION;
TRANSLATIONAL RESEARCH;
VASCULARIZATION;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CARCINOMA, HEPATOCELLULAR;
HUMANS;
LIVER NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
SIGNAL TRANSDUCTION;
TRANSLATIONAL RESEARCH;
TRANSLATIONAL MEDICAL RESEARCH;
|
|
EID: 77955718027
PISSN: 13419625
EISSN: None
Source Type: Journal
DOI: 10.1007/s10147-010-0090-5 Document Type: Editorial |
|
Times cited : (4)
|
|
References (1)
|
